Product Description
Omeprazole 99%min EP Pharmaceutical API Acid secretion inhibitors made in china 73590-58-6
AI Product Description
*The following content is generated by AI and is for reference only.
Omeprazole, a cornerstone in the treatment of acid-related gastrointestinal disorders, is widely recognized as a potent proton pump inhibitor (PPI). Manufactured to meet the rigorous standards of the European Pharmacopoeia (EP) with a purity of 99% minimum, this pharmaceutical API represents high-quality active ingredient suitable for global formulation. Chemically known as 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole, its molecular formula is C₁₇H₁₉N₃O₃S, and it carries the CAS Registry Number 28760-72-9. This compound functions by specifically inhibiting the hydrogen/potassium-ATPase enzyme system at the secretory surface of gastric parietal cells, thereby blocking the final step of gastric acid production.
The primary therapeutic applications of Omeprazole include the short-term treatment of active duodenal ulcers, gastric ulcers, and gastroesophageal reflux disease (GERD). It is also indicated for the maintenance of healing in these conditions and for the management of pathological hypersecretory conditions such as Zollinger-Ellison syndrome. Furthermore, it plays a critical role in combination therapy with antibiotics to eradicate Helicobacter pylori infections, which are a leading cause of peptic ulcer disease. The high-purity Chinese-manufactured version ensures consistency in bioavailability and stability, making it an essential raw material for generic drug manufacturers worldwide. Its efficacy has been extensively validated through decades of clinical use, establishing it as a first-line therapy for reducing gastric acidity and promoting mucosal healing. As a standard API compliant with EP specifications, it undergoes strict quality control regarding impurities, residual solvents, and crystalline form, ensuring safety and efficacy for patients globally. The availability of this high-grade ingredient supports the robust production of various dosage forms, including delayed-release capsules and tablets, addressing a significant portion of the global demand for effective acid suppression therapies.